Sweet Cherry
Anthocyanin-rich stone fruit with cardiometabolic promise
Nutrition per serving 1 cup pitted (138 g)
- Water 113.4 g83%
- Sugars 17.7 g13%
- Fibre 2.9 g2%
- Other carbs 1.5 g1%
- Protein 1.5 g1%
- Fat 0.3 g0%
| Nutrient | Per serving | % daily value |
|---|---|---|
| Potassium | 306 mg | 7% |
| Vitamin C | 9.7 mg | 11% |
| Fiber | 2.9 g | 10% |
| Copper | 0.08 mg | 9% |
| Manganese | 0.1 mg | 4% |
| Vitamin K | 2.9 mcg | 2% |
| Magnesium | 15 mg | 4% |
| Vitamin A | 4 mcg RAE | 0% |
Composition data: USDA FoodData Central ↗
What is Sweet Cherry?
Sweet Cherry (Prunus avium) is a fruit used for anti-inflammatory effects (lowers crp, ifn-γ in some trials). NutriDex grades the human evidence as Moderate. Sweet cherries (Prunus avium) are a low-energy, water-rich fruit whose polyphenols—especially anthocyanins and hydroxycinnamic acids—drive most of the studied bioactivity. In a 30-day single-blind randomized placebo-controlled trial in obese adults, a dark sweet cherry drink (200 mL twice daily) modestly lowered systolic and diastolic blood pressure and reduced pro-inflammatory IFN-γ, though a pooled meta-analysis of seven cherry RCTs found no significant overall blood-pressure effect. Observational and small interventional data link cherry intake to lower serum urate and roughly 35% fewer recurrent gout attacks (case-crossover data), but a dedicated meta-analysis was not feasible because of heterogeneity. The best-replicated benefits—accelerated muscle-strength recovery, reduced soreness, and improved sleep via melatonin—come overwhelmingly from tart cherry (Prunus cerasus), so they should not be assumed identical for sweet cherry. Most studies are small, short, and use concentrated juice or powder rather than whole fresh fruit, limiting how far results generalize to ordinary dietary servings. Overall the human evidence is best described as moderate and mechanistically plausible but heterogeneous, with sweet-cherry-specific clinical data still sparse. As a whole food, sweet cherries are a sensible, nutrient-dense choice regardless of the targeted-effect uncertainty.